<p>Comparison of Grade 3–4 toxicity rates between GEM combination therapy and GEM alone therapy.</p
The predicted (blue markers) and actual proportions (orange markers) of individuals that experience ...
<p>Comparison of clinical characteristics between the chemoradiotherapy group and the other therapy ...
<p>Toxic effects recorded from randomized controlled trials (Grade 3–4 Adverse Events).</p
<p>GEM, gemcitabine; TRs, toxicity rates; OR, odds ratio; CI, confidence interval.</p
<p>Comparison of objective response rate between GEM combination therapy and GEM alone therapy.</p
<p>Comparison of overall survival between GEM combination therapy and GEM alone therapy.</p
<p>Comparison of grade ≥3 toxicities between addition of vandetanib to chemotherapy and chemotherapy...
<p>Grade 3/4 toxic reactions synchronous combined therapy vs. chemotherapy or EGFR TKIs alone.</p
<p>Comparison of objective response rate and toxicity in therapy subgroups by type of malignancy.</p
<p>Comparison of objective tumor response rate between combined inhibition therapy and single inhibi...
<p>Comparison of efficacy between combined therapy and chemotherapy or EGFR TKIs alone.</p
<p>Comparison of progression-free survival between combined inhibition therapy and single inhibition...
<p>The incidence of adverse reactions in TCMBT plus ultraviolet irradiation compared to ultraviolet ...
<p>Comparison of disease-specific annual hazard rates by ER status and tumor grade.</p
<p>Footnotes: Hazard ratios when comparing each regimen with Gemcitabine (G), projected median overa...
The predicted (blue markers) and actual proportions (orange markers) of individuals that experience ...
<p>Comparison of clinical characteristics between the chemoradiotherapy group and the other therapy ...
<p>Toxic effects recorded from randomized controlled trials (Grade 3–4 Adverse Events).</p
<p>GEM, gemcitabine; TRs, toxicity rates; OR, odds ratio; CI, confidence interval.</p
<p>Comparison of objective response rate between GEM combination therapy and GEM alone therapy.</p
<p>Comparison of overall survival between GEM combination therapy and GEM alone therapy.</p
<p>Comparison of grade ≥3 toxicities between addition of vandetanib to chemotherapy and chemotherapy...
<p>Grade 3/4 toxic reactions synchronous combined therapy vs. chemotherapy or EGFR TKIs alone.</p
<p>Comparison of objective response rate and toxicity in therapy subgroups by type of malignancy.</p
<p>Comparison of objective tumor response rate between combined inhibition therapy and single inhibi...
<p>Comparison of efficacy between combined therapy and chemotherapy or EGFR TKIs alone.</p
<p>Comparison of progression-free survival between combined inhibition therapy and single inhibition...
<p>The incidence of adverse reactions in TCMBT plus ultraviolet irradiation compared to ultraviolet ...
<p>Comparison of disease-specific annual hazard rates by ER status and tumor grade.</p
<p>Footnotes: Hazard ratios when comparing each regimen with Gemcitabine (G), projected median overa...
The predicted (blue markers) and actual proportions (orange markers) of individuals that experience ...
<p>Comparison of clinical characteristics between the chemoradiotherapy group and the other therapy ...
<p>Toxic effects recorded from randomized controlled trials (Grade 3–4 Adverse Events).</p
DOI
Add to ORKG